Dr. Eric Singer Named Chair of the Kidney Cancer Association Board of Directors

The Kidney Cancer Association (KCA) has appointed Eric A. Singer, MD, MA, MS, FACS, FASCO, of The Ohio State University Comprehensive Cancer Center (OSUCCC), as Chair of the Board of Directors. His appointment was confirmed by the board during its November 2025 meeting.

Involvement with KCA

• Served on the Scientific Planning Committee for the KCA’s International Kidney Cancer Symposiums
• Member of the Medical Steering Committee since 2022
• Participation in mentorship programs and patient education initiatives

Professional Background

• Holds the Dave Lonaberger Endowed Chair in Urology
• Professor of Urology and Bioethics, Chief of the Division of Urologic Oncology, and Director of the Urologic Oncology Fellowship at The Ohio State University Comprehensive Cancer Center
• Research focuses on developing treatments for genitourinary malignancies through clinical trials
• Professional interests include bioethics, with an emphasis on informed consent, decision-making capacity, research ethics, and surgical ethics

Board Transition

Dr. Singer succeeds Dr. Bradley C. Leibovich, who previously led the board. Dr. Leibovich will continue to be involved as Transitioning Chair Emeritus.

About the Kidney Cancer Association

Founded in 1990, the Kidney Cancer Association is an international non-profit organization. It supports kidney cancer research through symposiums and grants, participates in legislative advocacy, and provides resources for patients, caregivers, and healthcare professionals.

OncoDaily

More about oncology news on OncoDaily